Daiwa Securities Group Inc. - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 141 filers reported holding PDL BIOPHARMA INC in Q3 2019. The put-call ratio across all filers is 0.84 and the average weighting 0.0%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q2 2020$2,0000.0%6440.0%0.00%
Q1 2020$2,0000.0%6440.0%0.00%
Q4 2019$2,0000.0%644
-24.5%
0.00%
Q3 2019$2,000
-33.3%
8530.0%0.00%
Q2 2019$3,0000.0%8530.0%0.00%
Q1 2019$3,000
+50.0%
8530.0%0.00%
Q4 2018$2,0000.0%8530.0%0.00%
Q3 2018$2,0000.0%8530.0%0.00%
Q2 2018$2,000
-33.3%
8530.0%0.00%
Q1 2018$3,000
-98.9%
853
-97.1%
0.00%
-100.0%
Q2 2014$283,000
-83.4%
29,644
-85.5%
0.00%
-84.6%
Q1 2014$1,701,000204,7190.01%
Other shareholders
PDL BIOPHARMA INC shareholders Q3 2019
NameSharesValueWeighting ↓
Argent Trust Co 41,405$102,2700.01%
Diversified Trust Co 11,029$26,4690.00%
HANCOCK WHITNEY CORP 128,396$00.00%
RHUMBLINE ADVISERS 612$1,5110.00%
Ancora Advisors LLC 4,948$00.00%
Westside Investment Management, Inc. 500$00.00%
View complete list of PDL BIOPHARMA INC shareholders